On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayApr 12, 2024 3:30 pm

NetworkNewsBreaks – Zoned Properties Inc. (ZDPY) Continues to Align with Evolving Cannabis Market

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is focusing on seizing direct-to-consumer real estate opportunities in the rapidly growing and regulated cannabis market. This is amid changing regulations and attitudes towards cannabis use, which are transforming the industry. “Cannabis businesses are expanding significantly as regulations evolve, leading to an increased demand for specialized, direct-to-consumer properties that include dispensaries, manufacturing or processing centers, and distribution hubs. Real estate investors are capitalizing on this demand by acquiring properties for rental income generation while potentially realizing significant property value appreciation as the industry grows,” a…

Continue Reading

FridayApr 12, 2024 2:00 pm

NetworkNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB) Poised to Stand Distinct in Energy Storage Industry

Turbo Energy (NASDAQ: TURB), a photovoltaic energy company based in Spain, is strongly positioned to capitalize on the growing demand for photovoltaic energy storage systems in the European Union with its patented Sunbox, an AI-powered solution for home and commercial photovoltaic installation. “Following the recent acquisition of an international patent, Turbo Energy is now strategically determining the countries for registration. ‘The result will be a unique energy storage solution that we believe will provide Turbo a leading position in this industry worldwide and help pave the way towards a more sustainable and energy-efficient future,’ stated Turbo,” a recent article reads.…

Continue Reading

FridayApr 12, 2024 1:49 pm

NetworkNewsBreaks – Upstream Bridges Investment Gap for Issuers

Upstream, a MERJ Exchange market and trading app, today published a blog article that discussed common investment difficulties for issuers and how Upstream Exchange is helping solve these challenges. The article noted that roadshows are a cornerstone of any successful listing, but issuers often face a gap between generating excitement and securing capital from global retail investors. This is because traditional processes make it difficult for global retail investors to access U.S., Canadian and other securities, hindering participation in upcoming offers. “The concept of direct exchange access with an app didn’t exist… until Upstream, a MERJ Exchange market. Upstream gives…

Continue Reading

FridayApr 12, 2024 1:30 pm

NetworkNewsBreaks – Bravo Multinational Inc. (BRVO) Positioning for Opportunity in Video Streaming Sector

Bravo (OTC: BRVO) is a company actively exploring opportunities in the entertainment, hospitality and technology sectors to generate long-term value for its shareholders through high-growth business ventures. “Bravo recently announced entering into an asset purchase agreement to acquire the assets of Streaming TVEE Inc., marking its entrance into the video streaming market… The company’s new streaming service, TVee NOW(TM), intends to offer linear TV, also known as traditional broadcast television, which uses cable and satellite networks through a joint venture with a third party. The joint venture is expected to close at a later date. The streaming platform will also…

Continue Reading

FridayApr 12, 2024 1:24 pm

NetworkNewsBreaks – Yahoo! Finance Publishes Article on Big Tech-Led Rebound in US Stocks

Yahoo Finance published an article that discussed the U.S. stock surge on Thursday as big tech stocks led a rebound from a sell-off fueled by Wednesday’s surprise uptick in consumer prices. The article noted that members of the “Magnificent 7” tech stocks, a group that includes Apple Inc. (NASDAQ: AAPL), Nvidia Corp. (NASDAQ: NVDA), Amazon.com Inc. (NASDAQ: AMZN), Alphabet Inc. (NASDAQ: GOOGL, GOOG), Microsoft Corp. (NASDAQ: MSFT), Meta Platforms Inc. (NASDAQ: META), and Tesla Inc. (NASDAQ: TSLA), helped lead the rally. “Apple and Nvidia were both up more than 4%, while Amazon gained more than 1.5% to hit its first…

Continue Reading

FridayApr 12, 2024 12:52 pm

NetworkNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Closes on Public Offering Valued at Estimated $5.2M

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has closed on its previously announced public offering. The offering was comprised of up to 2,234,043 shares of Class A LGVN common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 2,234,043 shares of Class A common stock, both offered at $2.35 per share and associated warrant. The announcement noted that the warrants are exercisable upon issuance for up to five years. The public offering resulted in gross…

Continue Reading

FridayApr 12, 2024 11:44 am

NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare

Sigyn Therapeutics (OTCQB: SIGY), a medical technology that creates medical solutions to treat life-threatening conditions, is developing a portfolio of technologies, including Sigyn Therapy(TM), ChemoPrep(TM), ChemoPure(TM) and ImmunePrep(TM), which have each been designed to overcome a current limitation in healthcare. “As it relates to pathogen-associated disorders, the company has advanced Sigyn Therapy(TM) from concept through product development and subsequently completed five invitro blood purification studies, which validated the ability of Sigyn Therapy(TM) to extract 12 different therapeutic targets from human blood plasma. As a result of these study outcomes, Sigyn Therapy is a candidate to treat a wide range of…

Continue Reading

FridayApr 12, 2024 11:37 am

NetworkNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Announces ‘Milestone Achievement’ on Journey to Developing PAX-101

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has completed the execution of three pivotal registration/validation batches of PAX-101, which is an IV formulation of suramin. According to the announcement, this is an important milestone achievement as the company works toward enabling a New Drug Application (“NDA”) submission to the U.S. Food and Drug Administration (“FDA”). Currently, the company anticipates submitting the NDA in Q4 2024; this will mark another key milestone as the company works toward the potential commercial availability in the United States of the first and only form of suramin for the…

Continue Reading

ThursdayApr 11, 2024 3:50 pm

NetworkNewsBreaks – Riley Exploration Permian Inc. (NYSE American: REPX) Closes on $65.2M Public Offering

Riley Exploration Permian (NYSE American: REPX), a growth-oriented, independent oil and natural-gas company, has released the pricing of its previously announced underwritten public offering. The offering is comprised of 2,100,000 shares of common stock at $27 per share; the offering includes 700,000 shares offered by the company and 1,400,000 shares being offered by REPX stockholders. In addition, Riley Permian granted the underwriters a 30-day option to purchase up to 315,000 additional shares of common stock at the public offering price, minus underwriting discounts and commissions. The option was fully exercised. According to the announcement, gross proceeds from the offering, which…

Continue Reading

ThursdayApr 11, 2024 3:47 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Looking to Advance Discussions for Accelerated Approval, New NDA for CNM-Au8(R) in 2024

Clene (NASDAQ: CLNN), alongside its wholly owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases. These include amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). “Clene’s lead candidate, CNM-Au8(R), is a gold nanocrystal suspension that has emerged as a promising candidate for the treatment of both ALS and MS… Despite the FDA’s decision in late 2023 against allowing Clene to move forward with an accelerated approval pathway based on initial biomarker data, Clene is diligently preparing supplemental data to provide additional supportive biomarker, survival and mechanistic…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217